Navigation Links
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Date:3/14/2010

"When treating patients with significant MR, clinicians need to consider the benefits of the available treatment options and an individual patient's risk factors to determine the best course of therapy," said Charles A. Simonton, M.D., FACC, FSCAI, divisional vice president, Medical Affairs, and chief medical officer, Abbott Vascular. "Based on the positive risk-benefit profile demonstrated in the EVEREST II randomized trial and other EVEREST trials, the MitraClip procedure has the potential to be an important addition to the current options for treating certain patients with significant MR."

The MitraClip system received CE Mark in March 2008. The MitraClip device is an investigational device in the United States, and is currently under review for approval by the U.S. Food and Drug Administration (FDA).

About the EVEREST II Trial

The EVEREST II pivotal trial is a multi-center, randomized clinical trial of 279 patients with moderate-to-severe (3+) or severe (4+) mitral regurgitation who were candidates for mitral valve surgery. The mean age for patients was 68 years, and patients in the trial tended to have more co-morbidities,
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
2. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
3. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
4. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
5. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
6. Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer
7. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
8. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
9. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
10. Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection
11. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... OTTAWA , July 6, 2015 /CNW/ - The Canadian ... its national immunization strategy to ensure that all Canadians ... strains of HPV (human papillomavirus) through immunization. The lack ... in Canada is needlessly putting ... "Infectious diseases, such as HPV, continue to pose a ...
(Date:7/6/2015)... Increase in R&D activities ... in Germany through 2020   ... report, " Germany Bioinformatics Market Forecast & Opportunities, 2020 ... is projected to register a CAGR of over 29% ... growth on account of rising government funding and initiatives, ...
(Date:7/6/2015)... , July 6, 2015 Cardinal Health today ... Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications ... customers, THDG was owned by Court Square Capital Partners. ... existing cash and new debt.  Headquartered ... Drug Group had revenues of approximately $450 million in ...
Breaking Medicine Technology:CPhA Calls for HPV Strategy for Young Men to Save Lives 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3
... Targets Nonsense Mutations; Addresses Underlying Cause of,Genetic Disorders ... 23, 2007 /PRNewswire/ -- New,preclinical data published online ... that PTC124, an investigational new drug,designed to bypass ... Duchenne muscular dystrophy (DMD). It is,estimated that approximately ...
... 2007 /PRNewswire/ --,An activity-based cost analysis demonstrated that ... weeks replaced thrice weekly,administration of epoetin alfa, hemodialysis ... more than $44,000 per year per 100,patients. These ... in hemodialysis patients, were presented today,during an oral ...
Cached Medicine Technology:Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 2Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 3Targeting Specific Mutations Reveals Promising New Approach to,Treating Genetic Disorders; Preclinical Data Published in Nature 4Prospective Model Outlined Potential Time and Cost Savings of,Once-Monthly Anemia Treatment 2Prospective Model Outlined Potential Time and Cost Savings of,Once-Monthly Anemia Treatment 3
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... proper reimbursement for radiology services and ADVOCATE is leading the transition. ADVOCATE, the ... coding expertise with their Top 10 Tips for ICD-10. The ten tips are ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the ... partnered with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ultrasound ... conditions. Screenings are affordable and accurate and run about an hour long with ...
(Date:7/6/2015)... ... July 06, 2015 , ... Seedstock today announced Pierre ... address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the Small ... , held at the University of California-San Diego, will explore solutions and methodologies that ...
(Date:7/6/2015)... Alameda County, CA (PRWEB) , ... July 06, ... ... Alameda County, CA area, Carlson & Associates has once again teamed up with ... funds helping homeless families to move toward self-sufficiency. FESCO was created especially to ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, ... to reduce their risk of having a fracture through the bone health screenings conducted ... Day. , “We are participating because our residents need this information to remain independent ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2
... Reduce heart attack risk and blood pressure, studies show , , ... omega-3 fatty acids in oily fish and vegetable cooking oils ... acids in vegetables and nuts help keep blood pressure low, ... Rica found that high intake of omega-3 fatty acids reduced ...
... families ... from inadequate regulations, PHILADELPHIA, July 7 ... elderly and the disabled is pushing,for quality standards in Pennsylvania ... Consumer Alliance (PALCA) formed this,year to ensure that new licensing ...
... NEW YORK, July 7 An aggressive marketing ... wisdom about the connection,between diet and acne. Frutels, ... claims the unthinkable: eating their chocolate,nutraceutical will clear ... chocolate is merely the delivery vehicle for,their nutritional ...
... half had experienced it before or during college, survey ... between partners, friends and acquaintances is common before and ... 910 undergraduates aged 17 to 22 (57.1 percent female) ... , Among the findings: , , 407 (44.7 ...
... Cells During, Their Menstrual Flow; Potential for Future Anti-Aging and Sports Medicine ... ... With today,s hectic,lifestyle, where most women are juggling careers, family, relationships,and ... in,the future is not something that readily comes to mind -- especially ...
... CCA Industries,Inc. (Amex: CAW ) declared today a ... shareholders of record as of August 1, 2008, payable on,September ... 31, 2008 were $17,389,985.,Net income was $790,692 and earnings per ... of $1,292,921 and earnings per,share of $0.18 fully diluted for ...
Cached Medicine News:Health News:Omega-3, Some Omega-6 Fatty Acids Boost Cardiovascular Health 2Health News:Omega-3, Some Omega-6 Fatty Acids Boost Cardiovascular Health 3Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 2Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 3Health News:New Coalition Presses for Quality Standards for Assisted Living Facilities in PA 4Health News:Dermatologists In Denial: Controversial New Chocolate Nutraceutical Claims to be Good for Your Skin 2Health News:Relationship Violence Common Among College Students 2Health News:Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Women's Menstrual Blood 2Health News:CCA Industries, Inc. Declares Its Seventeenth Consecutive Dividend 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: